<DOC>
	<DOCNO>NCT01088321</DOCNO>
	<brief_summary>The purpose study compare incidence rate infection among patient rheumatoid arthritis treat abatacept treated anti-rheumatic medication</brief_summary>
	<brief_title>Safety Study Abatacept Treat Rheumatoid Arthritis ( A )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Diagnosis rheumatoid arthritis Claims indicate infusion , injection , dispense abatacept , DMARD , BDM Age 18 year old time drug initiation Enrollment health plan least 6 continuous month lead time study drug initiation Below 18 year age time BDM DMARD initiation Lacking six month continuous enrollment prior initiation one study drug</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>